arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

NU SKIN ENTERPRISES, INC.

NUS
$5.50 ▲ +0.29 (+5.57%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
70 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

NU SKIN ENTERPRISES, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $265.1M
Dividend Yield
Revenue Growth -12.0%
Op. Margin 1.3%
ROIC 0.3%
FCF / Share $-0.37
Trailing P/E 137.5x
Price / Book 0.3x
FCF Yield
Debt / Equity 0.26
info Valuation on last close. End-of-day price, Aug 7, 2026.

70-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$320.61M
↓ -12.0%
Net Income Profit after all expenses
$1.84M
↓ -98.3%
Operating Margin Operating profit as % of sales
1.3%
↓ -80.0% 41th
FCF / Share Free cash flow per share
$-0.37
↓ -38.0%
Long-Term Debt Long-term obligations
$203.59M
— -0.3%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
48
Returns
86
Financial Health
69
Cash Quality
32

Dividend History

Dividend / share · sourced from SEC filings
$0.34 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 70 quarters